| Albert Clarke Darlington, MD | |
|
110 Wolf Rd, Albany, NY 12205-1244 | |
| (518) 454-0850 | |
| Not Available |
| Full Name | Albert Clarke Darlington |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 110 Wolf Rd, Albany, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306938733 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 78280 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Albert Clarke Darlington, MD 110 Wolf Rd, Albany, NY 12205-1244 Ph: (518) 454-0850 | Albert Clarke Darlington, MD 110 Wolf Rd, Albany, NY 12205-1244 Ph: (518) 454-0850 |
News Archive
Scientists at Karolinska Institutet in collaboration with Estonian Competence Centre on Health Technologies have developed a new gene expression analysis method to widen the usage of blood in biomarker discovery and analysis. Their paper is published in the journal Scientific Reports.
MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.
Demonstrating its commitment to delivering best-in-class clinical research solutions, Canfield Scientific has been named the exclusive worldwide distributor of the highly respected PRIMOS family of 3D optical systems.
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.
Cook Medical has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for its Formula™ Balloon-Expandable Renal Stent System. The approval includes both the Formula 414RX Balloon Expandable Renal Stent and the Formula 418 Balloon Expandable Renal Stent.
› Verified 8 days ago
Dr. James Thomas Pozniakas, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1971 Western Ave, Albany, NY 12203 Phone: 578-452-7030 Fax: 578-452-7370 | |
Elena Dolginova, PT Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 10b Madison Ave, Albany, NY 12203 Phone: 585-458-7910 | |
Dr. Elizabeth Rausch-phung, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Empire State Plz, Corning Tower Room 649, Albany, NY 12237 Phone: 518-473-4437 Fax: 518-474-1495 | |
James V Mcdonald, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Empire State Plaza, Albany, NY 12237 Phone: 518-473-1166 | |
Dr. Paul E. Lemanski, M.D., F.A.C.P. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Executive Park Dr, Albany, NY 12203 Phone: 518-458-2000 Fax: 518-458-1524 | |
Dr. Dominic John Belmonte, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 215 Washington Avenue Ext, Albany, NY 12205 Phone: 518-456-0128 |